» Articles » PMID: 26474496

Evidence of Macular Pigment in the Central Macula in Albinism

Overview
Journal Exp Eye Res
Specialty Ophthalmology
Date 2015 Oct 18
PMID 26474496
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Albinism represents a spectrum of disorders with diminished to absent amounts of melanin pigmentation including the posterior segment of the eye. Macular pigment (MP) consists of two main carotenoids, lutein and zeaxanthin, concentrated in the macula. MP serves as blue light absorbent, antioxidant, and may reduce chromatic aberration and glare. It remains unclear if albinos have detectable MP. The purpose was to investigate the distribution of MP in albino patients with psychophysical and imaging techniques.

Methods: MP was measured at the eccentricity of 0.5° by heterochromatic flicker perimetry (QuantifEye(®); Tinsley Precision Instruments Ltd.) or by scanning laser ophthalmoscopy (MPOD module, MultiColor Spectralis(®), Heidelberg Engineering, Heidelberg, Germany) in four albino patients, who were also investigated with multimodal ophthalmic imaging.

Results: Visual acuity ranged from 20/32 to 20/125, nystagmus was present in three patients, and all patients showed typical foveal hypoplasia on fundus exam and optical coherence tomography. Fundus autofluorescence (FAF) demonstrated various degrees of central FAF signal attenuation. Genetic testing was available in three patients and confirmed the diagnosis. Measurable amounts of MP were detected in all four patients and ranged from 0.05 to 0.24, which is below the normal range.

Conclusions: We conclude that MP can be demonstrated and measured in albinos. Further studies are needed to investigate MP accumulation following carotenoid supplementation and its impact on visual performance.

Citing Articles

Foveal abnormalities determined by optical coherence tomography angiography in children with history of retinopathy of prematurity.

Takagi M, Maruko I, Yamaguchi A, Kakehashi M, Hasegawa T, Iida T Eye (Lond). 2019; 33(12):1890-1896.

PMID: 31273311 PMC: 7002660. DOI: 10.1038/s41433-019-0500-5.


Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy.

Sauer L, Andersen K, Dysli C, Zinkernagel M, Bernstein P, Hammer M J Biomed Opt. 2018; 23(9):1-20.

PMID: 30182580 PMC: 8357196. DOI: 10.1117/1.JBO.23.9.091415.


Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment.

Sauer L, Andersen K, Li B, Gensure R, Hammer M, Bernstein P Invest Ophthalmol Vis Sci. 2018; 59(7):3094-3103.

PMID: 30025128 PMC: 6009392. DOI: 10.1167/iovs.18-23886.


Unmeasurable small size of foveal avascular zone without visual impairment in optical coherence tomography angiography.

Yokoyama T, Maruko I, Koizumi H, Ishikawa Y, Iida T Eye (Lond). 2018; 32(6):1062-1066.

PMID: 29398701 PMC: 5997770. DOI: 10.1038/s41433-017-0005-z.


Correlations Between Macular, Skin, and Serum Carotenoids.

Conrady C, Bell J, Besch B, Gorusupudi A, Farnsworth K, Ermakov I Invest Ophthalmol Vis Sci. 2017; 58(9):3616-3627.

PMID: 28728169 PMC: 5520678. DOI: 10.1167/iovs.17-21818.